Squamosamide Derivative FLZ Protects Pancreatic β-Cells from Glucotoxicity by Stimulating Akt-FOXO1 Pathway.

Squamosamide Derivative FLZ Protects Pancreatic β-Cells from Glucotoxicity by Stimulating Akt-FOXO1 Pathway.
复制标题

Squamosamide 衍生物 FLZ 通过刺激 Akt-FOXO1 途径保护胰腺 β 细胞免受糖毒性

DOI:
10.1155/2015/803986
复制
发表时间:
2015
影响因子:
4.3
通讯作者:
Ma X
Ma X
中科院分区:
医学3区
文献类型:
--
作者:
Kong X;Zhang L;Hua X;Ma X

文献摘要

参考文献

被引文献

相似文献

慢性高血糖增加细胞凋亡,减少葡萄糖刺激的胰岛素分泌。虽然保护剂已被广泛搜索,但迄今尚未发现。在这里,我们测试了FLZ,一种从中草药中合成的squamosamide衍生物,作为INS-1 E细胞和小鼠胰岛中抗葡萄糖毒性的潜在候选物。β细胞在30 mM葡萄糖中的慢性培养导致细胞活力进行性降低,伴有细胞凋亡增加和胰岛素分泌减少。FLZ以剂量依赖性方式逆转这些对细胞凋亡和胰岛素的影响。FLZ治疗也增加了叉头盒O 1蛋白磷酸化,减少其核定位。相反,FLZ增加胰腺和十二指肠同源框-1的表达及其核定位,增加p-Akt介导的效果。Akt选择性抑制剂MK-2206可完全阻断FLZ的抗糖毒性作用。此外,FLZ治疗增加胞浆ATP/ADP比值。综上所述,我们的结果表明FLZ可能是一种潜在的治疗药物,以治疗高血糖诱导的β细胞衰竭。
Chronic hyperglycemia increases apoptosis and reduces glucose-stimulated insulin secretion. Although protective agents have been searched extensively, none has been found so far. Here we tested FLZ, a synthetic derivative of squamosamide from a Chinese herb, as a potential candidate for antiglucotoxicity in INS-1E cells and mouse islets. Chronic culture of β-cells in 30 mM glucose caused progressive reduction of cell viability, accompanied with increased apoptosis and reduced insulin secretion. These effects on apoptosis and insulin were reversed by FLZ in a dose-dependent manner. FLZ treatment also increased forkhead box O1 protein phosphorylation and reduced its nuclear location. On the contrary, FLZ increased pancreatic and duodenal homeobox-1 expression and its nuclear localization, an effect mediated by increased p-Akt. Consistently, Akt selective inhibitor MK-2206 completely abolished antiglucotoxicity effect of FLZ. Furthermore, FLZ treatment increased cytosolic ATP/ADP ratio. Taken together, our results suggest that FLZ could be a potential therapeutic agent to treat the hyperglycemia-induced β-cell failure.
DOI: 10.1007/s00125-010-1973-8
发表时间: 2011-03
期刊: DIABETOLOGIA
影响因子: 8.2
作者:
Kluth, O.;Mirhashemi, F.;Scherneck, S.;Kaiser, D.;Kluge, R.;Neschen, S.;Joost, H. -G.;Schuermann, A.
通讯作者: Schuermann, A.
DOI: 10.1159/000335802
发表时间: 2011-01-01
影响因子: --
作者:
Lim, Sangbin;Rashid, Md Abdur;Kim, Sung Soo
通讯作者: Kim, Sung Soo
DOI: 10.1016/j.brainres.2013.12.026
发表时间: 2014-02-14
期刊: BRAIN RESEARCH
影响因子: 2.9
作者:
Bao, Xiu-Qi;Kong, Xiang-Chen;Zhang, Dan
通讯作者: Zhang, Dan
DOI: 10.1016/j.mce.2008.03.004
发表时间: 2008-09-10
影响因子: 4.1
作者:
Hou, Zhi-Qiang;Li, Hong-Liang;Li, Guang-Wei
通讯作者: Li, Guang-Wei
DOI: 10.2337/db06-0753
发表时间: 2007-02-01
期刊: DIABETES
影响因子: 7.7
作者:
Park, Keun-Gyu;Lee, Kyeong-Min;Lee, In-Kyu
通讯作者: Lee, In-Kyu